| Jonathan Karnes, MD | |
|
6 E Chestnut St, Augusta, ME 04330-5758 | |
| (207) 623-6680 | |
| (207) 623-6609 |
| Full Name | Jonathan Karnes |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 6 E Chestnut St, Augusta, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306046180 | NPI | - | NPPES |
| NONE | Other | ME | RESIDENT-NO PROV # |
| 432680199 | Medicaid | ME |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine General Medical Center | Augusta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainegeneral Medical Center | 1254245715 | 487 |
News Archive
Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review.
Researchers at the University of Cincinnati Interstitial Lung Disease Center have received a grant from the National Heart, Lung and Blood Institute to study ways ILD first appears in certain patient groups with autoimmune diseases and how to more efficiently diagnose and treat it.
On January 1, 2013, the German Research Foundation (DFG) will establish a new Collaborative Research Center (CRC) at the University Medical Center of Johannes Gutenberg University Mainz (JGU).
Researchers at Worcester Polytechnic Institute's (WPI) Life Sciences and Bioengineering Center at Gateway Park have received a total of $1.3 million in new awards from the National Institutes of Health (NIH) and the National Science Foundation (NSF) to fund ongoing research in several areas of the life sciences, including a study of the bacterium that causes tuberculosis, work aimed at using adult stem cells to repair damaged hearts, and a project that seeks to create engineered blood vessels.
CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.
› Verified 4 days ago
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review.
Researchers at the University of Cincinnati Interstitial Lung Disease Center have received a grant from the National Heart, Lung and Blood Institute to study ways ILD first appears in certain patient groups with autoimmune diseases and how to more efficiently diagnose and treat it.
On January 1, 2013, the German Research Foundation (DFG) will establish a new Collaborative Research Center (CRC) at the University Medical Center of Johannes Gutenberg University Mainz (JGU).
Researchers at Worcester Polytechnic Institute's (WPI) Life Sciences and Bioengineering Center at Gateway Park have received a total of $1.3 million in new awards from the National Institutes of Health (NIH) and the National Science Foundation (NSF) to fund ongoing research in several areas of the life sciences, including a study of the bacterium that causes tuberculosis, work aimed at using adult stem cells to repair damaged hearts, and a project that seeks to create engineered blood vessels.
CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Karnes, MD 6 E Chestnut St, Augusta, ME 04330-5758 Ph: (207) 623-6680 | Jonathan Karnes, MD 6 E Chestnut St, Augusta, ME 04330-5758 Ph: (207) 623-6680 |
News Archive
Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review.
Researchers at the University of Cincinnati Interstitial Lung Disease Center have received a grant from the National Heart, Lung and Blood Institute to study ways ILD first appears in certain patient groups with autoimmune diseases and how to more efficiently diagnose and treat it.
On January 1, 2013, the German Research Foundation (DFG) will establish a new Collaborative Research Center (CRC) at the University Medical Center of Johannes Gutenberg University Mainz (JGU).
Researchers at Worcester Polytechnic Institute's (WPI) Life Sciences and Bioengineering Center at Gateway Park have received a total of $1.3 million in new awards from the National Institutes of Health (NIH) and the National Science Foundation (NSF) to fund ongoing research in several areas of the life sciences, including a study of the bacterium that causes tuberculosis, work aimed at using adult stem cells to repair damaged hearts, and a project that seeks to create engineered blood vessels.
CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.
› Verified 4 days ago
Rachel Thomas, Family Medicine Medicare: Medicare Enrolled Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561 Fax: 207-626-1849 | |
Cheryl K Seymour, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561 Fax: 207-626-1849 | |
Paul T. Renaud, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Mc 845, Augusta, ME 04330 Phone: 207-626-1206 Fax: 207-626-1648 | |
Josee Proulx, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561 Fax: 207-626-1849 | |
Shannon Kenney, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Va Ctr, Department Of Veterans Affairs, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-621-4844 | |
Dr. David A York, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 219 Capitol St, Ste 2, Augusta, ME 04330 Phone: 207-629-5005 Fax: 207-629-5220 | |
Cassandra Generlette, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15 E Chestnut St, Augusta, ME 04330 Phone: 207-626-1561 Fax: 207-626-1849 |